People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

22.35USD
30 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$22.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
209,230
52-wk High
$28.48
52-wk Low
$18.28

Search Stocks

Abdun-Nabi, Daniel 

Brief Biography

Mr. Daniel J. Abdun-Nabi is President, Chief Executive Officer, Director of Emergent BioSolutions Inc. From May 2007 to March 2012, Mr. Abdun-Nabi served as the president and chief operating officer. Mr. Abdun-Nabi previously served as the secretary from December 2004 to January 2008, the senior vice president, corporate affairs and general counsel from December 2004 to April 2007 and the vice president and general counsel from May 2004 to December 2004. Mr. Abdun-Nabi served as general counsel for IGEN International, Inc., a biotechnology company, and its successor BioVeris Corporation, from September 1999 to May 2004. Prior to joining IGEN, Mr. Abdun-Nabi served as senior vice president, legal affairs, general counsel and secretary of North American Vaccine, Inc. Mr. Abdun-Nabi received an M.L.T. in taxation from Georgetown University Law Center, a J.D. from the University of San Diego School of Law and a B.A. in political science from the University of Massachusetts, Amherst.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,048,880 -- 1,111,970 2,160,850

Options Compensation

  Quantity Market Value
Exercisable 25,900 --
Unexercisable 11,100 --
Exercised 173,448 2,678,520.00
Name Fiscal Year Total

Fuad El-Hibri

1,295,470

Daniel Abdun-Nabi

2,160,850

Robert Kramer

800,747

Anatolio Cruz

--

Adam Havey

805,364

Barry Labinger

138,944
As Of 30 Dec 2013
Search Stocks